₹-7.19
(Market cap
₹182 Cr
Recently Viewed
Clear AllMarket cap
₹182 Cr
Revenue (TTM)
₹27 Cr
P/E Ratio
87.5
P/B Ratio
5.5
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹2 Cr
ROE
7.1 %
ROCE
10 %
Industry P/E
36.66
EV/EBITDA
57.4
Debt to Equity
0
Book Value
₹30.2
EPS
₹1.9
Face value
10
Shares outstanding
11,020,000
CFO
₹48.15 Cr
EBITDA
₹55.17 Cr
Net Profit
₹19.96 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Arvee Laboratories
| -22.8 | 16.6 | 9.0 | 13.6 | 11.5 | 8.5 | -- |
|
BSE Commodities
| 5.1 | 15.1 | 5.2 | 14.0 | 18.0 | 13.5 | 16.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Arvee Laboratories
| 21.2 | 0.3 | 33.4 | 48.6 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 |
|
BSE Commodities
| 12.5 | 8.1 | 17.5 | 1.2 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Arvee Laboratories
|
164.8 | 181.6 | 27.2 | 2.1 | 4.2 | 6.6 | 87.5 | 5.5 |
| 472.8 | 17,123.5 | 8,045.0 | 378.0 | 7.8 | 6.6 | 45.3 | 2.9 | |
| 1,113.8 | 14,781.9 | 1,088.6 | 215.8 | 27.4 | 9.8 | 68.5 | 6.2 | |
| 1,341.0 | 15,287.6 | 2,229.8 | 229.1 | 18.1 | 5.7 | 88.9 | 4.7 | |
| 1,690.3 | 23,051.8 | 7,946.4 | 533.3 | 8.9 | 9.9 | 43.2 | 4.1 | |
| 4,851.5 | 14,869.5 | 2,347.3 | 398.8 | 17.9 | 16.4 | 37.5 | 5.8 | |
| 4,035.9 | 9,366.1 | 2,071.4 | 307.8 | 17.4 | 12.6 | 30.4 | 3.7 | |
| 738.6 | 11,765.3 | 4,260.9 | 265.7 | 9.0 | 9.2 | 44.3 | 3.8 | |
| 3,232.6 | 12,623.7 | 2,455.7 | 286.6 | 18.6 | 25.6 | 42 | 9.6 | |
| 1,280.6 | 13,283.2 | 2,271.4 | 442.9 | 24.7 | 15.5 | 30 | 4.4 |
No Review & Analysis are available.
Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono... lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid. It also provides drug intermediates comprising 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4"amino pyridine, and 2"chloro"5"nitrobenzoic acid. In addition, the company exports its products. Arvee Laboratories (India) Ltd. was incorporated in 2012 and is based in Ahmedabad, India. Read more
Incorporated
2012
Chairman
Shalin Sudhakarbhai Patel
Managing Director
Shalin Sudhakarbhai Patel
Headquarters
Ahmedabad, Gujarat
Website
Looking for more details about Arvee Laboratories (India) Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Announcements
View Announcements
The share price of Arvee Laboratories (India) Ltd is ₹164.76 (NSE) as of 24-Apr-2026 IST. Arvee Laboratories (India) Ltd has given a return of 11.55% in the last 3 years.
The P/E ratio of Arvee Laboratories (India) Ltd is 87.54 times as on 24-Apr-2026, a 139 premium to its peers’ median range of 36.66 times.
The P/B ratio of Arvee Laboratories (India) Ltd is 5.46 times as on 24-Apr-2026, a 149 premium to its peers’ median range of 2.19 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
72.87
|
5.01
|
|
2024
|
150.24
|
5.43
|
|
2023
|
23.54
|
3.46
|
|
2022
|
48.68
|
5.23
|
|
2021
|
22.80
|
2.86
|
The 52-week high and low of Arvee Laboratories (India) Ltd are Rs 290.78 and Rs 129.11 as of 25-Apr-2026.
Arvee Laboratories (India) Ltd has a market capitalisation of ₹ 182 Cr as on 24-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Arvee Laboratories (India) Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.